Elevation Oncology Inc (ELEV)

09:53 AM

Elevation Oncology completes merger with Concentra Biosciences, delists from Nasdaq - Investing.com

09:53 AM

09:50 AM

Elevation Oncology Completes Merger with Concentra Biosciences - TipRanks

09:50 AM

04:43 AM

Elevation Oncology Inc. Stock Analysis and ForecastSignificant capital appreciation - Autocar Professional

04:43 AM

Jul 22, 2025

Elevation Oncology, Inc.(NasdaqCM: ELEV) dropped from S&P TMI Index - MarketScreener

Jul 22, 2025

Jul 22, 2025

What drives Elevation Oncology Inc. stock priceAccelerated investment success - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Elevation Oncology Inc. stockFree Market Dynamics Reports - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

Is Elevation Oncology Inc. a good long term investmentFree Expert Stock Watchlist - jammulinksnews.com

Jul 20, 2025

Jul 17, 2025

what makes elevation oncology inc. stock price move sharplySmart Trading With Safety Margin - Newser

Jul 17, 2025

Jul 16, 2025

What makes Elevation Oncology Inc. stock price move sharplyIntraday Trade Ideas - beatles.ru

Jul 16, 2025

Jul 15, 2025

Why Elevation Oncology Inc. stock attracts strong analyst attentionMomentum Buy Alert - beatles.ru

Jul 15, 2025

Jul 15, 2025

How Elevation Oncology Inc. stock performs during market volatilityMulti Bagger Alerts - Newser

Jul 15, 2025

Jul 04, 2025

Elevation Oncology Terminates EO-3021 Study Amid Implications for Future Research and Development Strategies - AInvest

Jul 04, 2025

Jul 03, 2025

EO-3021 Study Termination: Implications for Elevation Oncology and Partners - TipRanks

Jul 03, 2025

Jul 02, 2025

Elevation Oncology Terminates License Agreement with CSPC - TipRanks

Jul 02, 2025

Jul 02, 2025

Elevation Oncology ends license agreement with CSPC Megalith Biopharmaceutical - Investing.com

Jul 02, 2025

Jun 30, 2025

Elevation Oncology, Inc. (NASDAQ:ELEV) Receives $3.39 Average PT from Brokerages - Defense World

Jun 30, 2025

Jun 17, 2025

Analyzing Ratios: Elevation Oncology Inc (ELEV)’s Financial Story Unveiled - DWinneX

Jun 17, 2025

Jun 16, 2025

Elevation Oncology, Inc. (NASDAQ:ELEV) Sees Large Decline in Short Interest - Defense World

Jun 16, 2025

Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, ELEV, MTWO, CRKN on Behalf of Shareholders - GlobeNewswire Inc.

Jun 15, 2025

Jun 14, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 14, 2025

Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView

Jun 13, 2025

Jun 13, 2025

Research Analysts Set Expectations for ELEV FY2025 Earnings - Defense World

Jun 13, 2025

Jun 13, 2025

Q2 Earnings Estimate for ELEV Issued By Leerink Partnrs - Defense World

Jun 13, 2025

Jun 12, 2025

Equities Analysts Issue Forecasts for ELEV Q3 Earnings - Defense World

Jun 12, 2025

Jun 12, 2025

Wedbush Forecasts Reduced Earnings for Elevation Oncology - Defense World

Jun 12, 2025

Jun 12, 2025

Elevation Oncology (NASDAQ:ELEV) Cut to “Hold” at TD Cowen - Defense World

Jun 12, 2025

Jun 11, 2025

HC Wainwright Downgrades Elevation Oncology (NASDAQ:ELEV) to Neutral - Defense World

Jun 11, 2025

Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Stock Rating Lowered by HC Wainwright - Defense World

Jun 11, 2025

Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Downgraded by HC Wainwright to Neutral - Defense World

Jun 11, 2025

Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Receives Market Perform Rating from JMP Securities - Defense World

Jun 11, 2025

Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Lowered to Hold Rating by William Blair - Defense World

Jun 11, 2025

Jun 11, 2025

Elevation Oncology’s (ELEV) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Jun 11, 2025

Jun 10, 2025

ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc.ELEV - Business Wire

Jun 10, 2025

Jun 10, 2025

Elevation Oncology (ELEV) Receives Analyst Rating Update | ELEV Stock News - GuruFocus

Jun 10, 2025

Jun 10, 2025

This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday - Benzinga

Jun 10, 2025

Jun 10, 2025

Elevation Oncology (ELEV) Receives Downgrade from HC Wainwright & Co. | ELEV Stock News - GuruFocus

Jun 10, 2025

Jun 10, 2025

TD Cowen Downgrades Elevation Oncology to Hold From Buy - MarketScreener

Jun 10, 2025

Jun 10, 2025

HC Wainwright Downgrades Elevation Oncology to Neutral From Buy - marketscreener.com

Jun 10, 2025

Jun 10, 2025

Elevation Oncology (ELEV) Downgraded by H.C. Wainwright Amid Mer - GuruFocus

Jun 10, 2025

Jun 10, 2025

Elevation Oncology agrees to be acquired by Concentra - The Pharma Letter

Jun 10, 2025